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Summary
in the present study, we demonstrated that expression of the LFA1 molecule is necessary for
cell fusion and syncytia formation in human immunodeficiency virus (HIV)-infected CD4+ T
lymphocytes. In contrast, the lack ofexpression ofLFA-1 does not influence significantly cell-to-
cell transmission of HIV In fact, LFA-1 - T lymphocytes obtained from a leukocyte adhesion
deficiency patient were unable to fuse and form syncytia when infected with HIV-1 or HIV2,
despite the fact that efficiency of HIV infection (i.e., virus entry, HIV spreading, and levels of
virus replication) was comparable with that observed in LFA-1 + T lymphocytes . In addition,
we provide evidence that LFA-1 by mediating cell fusion contributes to the depletion of HIV
infected CD4+ T lymphocytes in vitro.
C
ell fusion and syncytia formation of HIV-infected cells
are dependent on a direct interaction ofHIV envelope
glycoprotein with the CD4 molecule (1-4) . However, mole-
cules that regulate cell-to-cell adhesion, such as LFA-1 (5),
may play a potentially important role in the spreading ofHIV
and in the process of cell fusion of HIV-infected CD4+ lym-
phocytes (6, 7) . In fact, it has been previously shown that
mAbs directed against theLFA1 molecule block direct cell-
to-cell transmission of HIV (7), as indicated by inhibition
of syncytia formation (6) and virus replication (7) in HIV
infected cells treated with anti-LFA-1 mAb. However, the rel-
ative importance of the interaction between HIV envelope
and theCD4 molecule vs . LFA-1-related cell-to-cell adhesion
in the process of HIV transmission and cell fusion remains
to be elucidated .
To address this question, we have used leukocytes geneti-
cally deficient in LFA-1 expression as target cells forHIV in-
fection . Leukocytes from patients with leukocyte adhesion
deficiency(LAD) are deficient in the expression of three trans-
membrane glycoproteins, termed LFA-1, Mac-1, and p150,95,
which are heterodimers formed between one of three CD11
subunits and a common CD18 subunit (8) . Leukocytes from
LAD patients, therefore, represent an ideal and natural model
system to assess the role of LFA-1 in the spreading of HIV
and in HIV-mediated cell fusion .
We demonstrate that cell fusion and syncytia formation
do not occur in LFA-1 - mononuclear cells despite efficient
HIV infection, thus indicating thatLFA1 is required for HIV
mediated cell fusion but does not seem to be involved in cell-
to-cell transmission of HIV In addition, HIVmediated
cytopathicity was more pronounced in LFA-1+ vs. LFA-1'
mononuclear cells .
Materials and Methods
mAb andFlow Cytojluommetric Analysis.
￿
FITC-conjugated Leu-3
a+ bmAb (Becton Dickinson Immunocytometry Systems, San Jose,
CA), purified anti-LFA-1 (MHM23) mAb, which recognizes the
a chain of LFA-1 molecule (9) (a generous gift of Dr. S. Shaw,
Experimental Immunology Branch, NCI, NIH, Bethesda, MD),
anti-ICAM-1 (RR11) and anti-ICAM-2 mAb (kindly provided by
Dr. T Springer, Department ofPathology, Harvard Medical School,
and the Center for Blood Research, Boston, MA), and human anti-
gp41 mAb (kindly provided by Dr. S . Zolla-Pazner, Department
of Pathology, New York University Medical Center, New York)
were used for phenotypic analyses, which were performed as previ-
ously described (10) . OKT4a mAb (Ortho Pharmaceutical, Rar-
itan, NJ) was used for inhibition of syncytia formation .
Isolation ofLymphoid Cells.
￿
Lymphocytes were isolated from pe-
ripheral blood over a Hypaque-Ficoll density gradient .
Cell Cultures. LFA-1 - and LFA-1+ PBMC were stimulated
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511-514for 72 h with PHA (2 Ftg/ml) (Sigma Chemical Co., St . Louis,
MO) and inoculated either with supernatants (SNs) containing
HIV1t.AV (10-4 dilution of the viral stock) or HIV2aoD (10-3 di-
lution of the viral stock) . 10' HIV-1- or HIV-2-infected PHA-
activated cells (6 x 105/well) resuspended in culture medium
(RPMI 1640 plus 10% FCS and rI1r2 [50 U/mIJ) were plated in
48-well flat-bottomed plates (Costar, Cambridge, MA) . Beginning
on day 2 after infection, 50 P .l of culture SN was removed daily
from each well, pooled, stored at -70°C, and subsequently as-
sayed for reverse transcriptase (RT) activity, which was measured
as previously described (11) .
PCR Analysis.
￿
PHA-activated (3 d) LFA-1 - and LFA-1* cells
(2 x 10 6/ml) were inoculated withSN (10-2 dilutions ofthe viral
stock) containing HIV-1 (strain LAV) for 6 h, washed twice, replaced
in culture for an additional 18 h and prepared for PCR as previ-
ously described (12) . Primer pairs used in these experiments in-
cluded SK 145/101 (gag),SK 29/30(LTR), andQH 26/27 (HLA-
DQa control) (Synthetic Genetics, San Diego, CA). Amplified prod-
ucts were hybridized to -y-[32P]ATP end-labeled probes (SK 102
andSK 31 for the gag andLTR primers, respectively) and analyzed
on 10% polyacrylamide gels . Autoradiograms (Kodak, Rochester,
NY) of the gels were obtained after 6 h of exposure.
Results and Discussion
LFA-1- PBMC obtained from one LAD patient (13) and
LFA-1 + PBMC from three normal donors were activated for
72 h with PHA, exposed to SNs containing an HIV-1 iso-
late, and then analyzed for the presence of HIV DNA by
PCR amplification, followed by hybridization with probes
for HIV gag and LTR gene segments. Comparable proviral
DNA signals were found in both LFA1 - and LFA1+ cells
(Fig. 1 A), indicating that lack of expression of the LFA-1
molecule does not prevent HIV entry into cells . Moreover,
similar peak levels of virus replication, as measured by RT
activity, were observed in SNs fromLFA1 - and LFA1+ cell
cultures infected with HIV1; however, a delay in the peak
of virus replication was observed in the LFA-1 - cell cultures
(Fig. 1 B) . Similar results were obtained in the LFA1 - cell
cultures infected with HIV-2 (data not shown) . Therefore,
lack of expression of the LFA-1 molecule may moderately
slow the spreading ofHIV in T lymphocytes, but transmis-
sion ofHIV will nonetheless occur as a consequence of the
well-recognized mechanism ofCD4-gp120 interaction (1-4) .
We then assessed the role of the LFA-1 molecule in the
process of HIV-mediated syncytia formation . LFA1+ cell
cultures infected either with HIV-1 or HIV-2 showed forma-
tion of syncytia beginning at day 3 after infection (data not
shown) and reached a peak at day 5 (Fig . 2, C and D) . In
contrast, formation of syncytia was never observed in the
LFA1 - cell cultures productively infected either with HIV-1
(Fig. 2 B) or HIV-2 (data not shown) . Of note is the fact
that expression of the gp41 fusogenic component of HIV
envelope (14, 15) was similar (N20%) in both HIV-1- and
HIV-2-infected LFA-1+ and LFA1- cell cultures, as deter-
mined by positive staining with anti-gp41 mAb (16) (data
not shown) . Further evidence that LFA-1 is the key molecule
in the process of HIV-mediated cell fusion was obtained by
restoring LFAI-mediated cell-to-cell interactions by cocul-
ture experiments . Maximal syncytia formation was observed
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Figure 1.
￿
(A) Oligomer hybridization ofamplified HIV-1 (LAV)DNA
from in vitro infected PHA-activated LFA-1- and LFA-l' cells . Intensity
of thePCR signals in 105 LFA-1 - cells and 105 LFA-1I cells from three
different donors are compared (TE, buffer control ; DNA lysates from 105
Jurkat, negative control; DNA lysates from 102 ACH2, a cell line con-
taining a single proviral copy of HIV per cell [121, positive control) . The
results shown were obtained using gag primer pairs and probe. Similar
results were obtained withLTRprimer pairs and probe . (B) Comparative
analysis of the levels of virus replication in LFA-1- and LFA-1* cell cul-
tures. Levels of virus replication in LFA-1 - (O) and LEA-1 ` (" ) cells in-
fected withHIV1 . LFA-1- and LFA-1* PBMC were stimulated for 72 h
withPHA and inoculated with SNs containing HIV1LAV . The levels of
RT activity observed in HIV-infected LFA 1 - cell cultures are represen-
tative of three independent experiments and are compared with levels of
RT activity (mean *_ SD) in HIV-infected LFA-1' cell cultures from six
normal donors .
12 h after coculturing HIV-1 or HIV-2-infected LFA1 - cells
(3.5 x 105 cells), which expressed normal levels ofICAM-1
and ICAM-2 antigens (data not shown), with 3.5 x 105
uninfected LFA1+ PHA-activated lymphocytes (data not
shown) . In addition, pretreatment (45 min at 37°C) of
uninfected LFA1+ cells with either anti-LFA1 (10 p,g/ml)
or OKT4a (1 p,g/ml) mAb before coculture with HIV-2-
infected LFA1 - cells resulted in complete suppression of
syncytia formation (data not shown) . These results demon-
strate that : (a) surface expression of the LFA-1 molecule is
necessary for cell fusion and syncytia formation in HIVinfected
CD4+ T lymphocytes ; (b) CD4-gp120 interaction and sig-
nificant surface expression of the gp41 fusion domain ofHIV
envelope are events not sufficient to cause cell fusion ; (c) CD4-
gp120 interaction, however, is required for LFA-1-mediated
cell fusion, as indicated by the inhibition of syncytia forma-
tion with OKT4a mAb in the coculture experiments ; and
(d) syneytia formation is not necessary for extensive spreading
of HIV and virus replication .
We next investigated the importance of LFAI-mediated
cell fusion of HIVinfectedT lymphocytes as a potential mech-
anism for HIV-mediated depletion ofCD4+ T lymphocytes .
In LFA1+ cell cultures infected either with HIV-1 or HIV-2,
a major depletion in CD4+ T lymphocytes (50-70% reduc-
tion) was observed between days 4 and 6 (Fig . 3, A-C and
E-G), the period of time corresponding to the presence of
syncytia and to the peak of virus replication . 10-12 d after
infection, depletion ofCD4+ cells in HIVinfected LFA1+
cultures was>90% compared with uninfected cultures (Fig .
3, A-C and E-G) . In contrast, in LFAI - cell cultures in-
fected either with HIV-1 or HIV-2, syncytia formation was
never observed, and the rate and the extent of depletion of
CD4+ T lymphocytes were significantly less than those ob-A
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Figure 2 .
￿
Role of the LEA-1 mole-
cule in cell fusion and syncytia forma-
tion . Small clumps, but not syncytia,
were observed in uninfected (A) and in
HIV-1 (B) orHIV-2 (data not shown)
-infected LFA-1 - cell cultures. In con-
trast, syncytia formation (arrows) oc-
curred in LFA-1+ cell cultures infected
with HIV-1 (C), and to a greater ex-
tent in those infected with HIV-2 (D) .
Photomicrographs (x75) were taken at
day 5 afterinfection in the experiments
in B-D . Cultures were scored dailyfor
syncytia formation. Infection of PHA-
activated LFA-1 - and LFA-1 + cells
with HIV-1 and HIV-2wereperformed
as described in Materials and Methods .
1
Figure 3 . Involvement of the
LFA-1 molecule -in HIV-mediated
depletion ofCD4+ T lymphocytes .
In A-C and E-G, PHA-activated
LFA-1+ cells infected with HIV-1
and HIV-2, respectively, were ob-
tained from three normal donors. In
D and H, PHA-activated LFA-1-
cells were infected with HIV-1 and
HIV-2, respectively. (") Levels of
RT activity; (") percentage of
CD4+ cells in uninfected cultures;
(O) percentage of CD4+ cells in
cell cultures infected either with
HIV-1 or HIV-2. Infection ofPHA-
activated LFA-1 - and LFA-1+ cells
with HIV-1 and HIV-2 and the
staining of CD4+ cells were per-
formed as described in Materialsand
Methods .served in HIVinfected LFA-1+ cell cultures (Fig. 3, D and
M . For example, 10-12 d after HIV-1 or HIV-2 infection of
LFA1 - cell cultures, the depletion ofCD4+ T lymphocytes
was 30-50% compared with uninfected cell cultures (Fig.
3, D andM . However, an almost complete depletion of
LFA-1 - CD4+ T lymphocytes was observed by adding
uninfected PHA-activated LFA-1+ cells and thus restoring
LFA-1 mediated cell fusion (90% reduction in CD4+ cells
5 d after initiating the coculture ; data not shown) . Taken
together, these results indicate that LFA-1 by mediating cell
fusion in HIV-infected CD4+ T lymphocytes contributes
significantly to the depletion of CD4+ T lymphocytes by
HIV infection in vitro.
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In conclusion, expression of the LFA1 molecule in HIV
infected CD4+ T lymphocytes is associated with optimal
spreading, cell fusion, and high cytopathicity. In contrast,
the lack of surface expression ofLFA1 abolishes the process
of cell fusion in HIV-infected CD4+ T lymphocytes, despite
the fact that the gp41 fusion domain is expressed .
The observation that LFA-1 is critically involved in syn-
cytia formation, together with the previously described role
ofviral gp41 in this process (14, 15), leads us to hypothesize
that a direct interaction between gp41 and LFA-1 is required
for HIV-mediated cell fusion . If this hypothesis is correct,
disrupting this interaction could provide an attractive new
therapeutic strategy for HIV infection.
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